Levorphanol Tartrate: payments to doctors
Payments that named Levorphanol Tartrate as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $195K
- Providers
- 2,462
- Transactions
- 8,864
- Average per transaction
- $22
The per-transaction average — $22 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,462 providers the average total is $79, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Virtus Pharmaceuticals LLC | $142,025 | 72.9% |
| Sentynl Therapeutics, Inc. | $52,820 | 27.1% |